These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 1980339)
1. Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells. Klein E; Di Renzo L; Yefenof E Mol Immunol; 1990 Dec; 27(12):1343-7. PubMed ID: 1980339 [TBL] [Abstract][Full Text] [Related]
2. Requirement of leukocytic cell adhesion molecules (CD11a-c/CD18) in the enhanced NK lysis of iC3b-opsonized targets. Ramos OF; Patarroyo M; Yefenof E; Klein E J Immunol; 1989 Jun; 142(11):4100-4. PubMed ID: 2565929 [TBL] [Abstract][Full Text] [Related]
3. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505 [TBL] [Abstract][Full Text] [Related]
4. Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules. Vĕtvicka V; Hanikýrová M; Vĕtvicková J; Ross GD Clin Exp Immunol; 1999 Feb; 115(2):229-35. PubMed ID: 9933447 [TBL] [Abstract][Full Text] [Related]
5. Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18). Roubey RA; Ross GD; Merrill JT; Walton F; Reed W; Winchester RJ; Buyon JP J Immunol; 1991 May; 146(10):3557-62. PubMed ID: 1673986 [TBL] [Abstract][Full Text] [Related]
6. Elevated NK-mediated lysis of Raji and Daudi cells carrying fixed iC3b fragments. Ramos OF; Nilsson B; Nilsson K; Eggertsen G; Yefenof E; Klein E Cell Immunol; 1989 Apr; 119(2):459-69. PubMed ID: 2522826 [TBL] [Abstract][Full Text] [Related]
7. The function of human NK cells is enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18). Di Renzo L; Yefenof E; Klein E Eur J Immunol; 1991 Jul; 21(7):1755-8. PubMed ID: 2060581 [TBL] [Abstract][Full Text] [Related]
8. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568 [TBL] [Abstract][Full Text] [Related]
9. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. Vetvicka V; Thornton BP; Ross GD J Clin Invest; 1996 Jul; 98(1):50-61. PubMed ID: 8690804 [TBL] [Abstract][Full Text] [Related]
10. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. Schlesinger LS; Horwitz MA J Immunol; 1991 Sep; 147(6):1983-94. PubMed ID: 1679838 [TBL] [Abstract][Full Text] [Related]
11. CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. Muto S; Vĕtvicka V; Ross GD J Clin Immunol; 1993 May; 13(3):175-84. PubMed ID: 8100571 [TBL] [Abstract][Full Text] [Related]
12. Macrophage cytoskeleton association with CR3 and CR4 regulates receptor mobility and phagocytosis of iC3b-opsonized erythrocytes. Ross GD; Reed W; Dalzell JG; Becker SE; Hogg N J Leukoc Biol; 1992 Feb; 51(2):109-17. PubMed ID: 1358992 [TBL] [Abstract][Full Text] [Related]
13. The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes. Lukácsi S; Nagy-Baló Z; Erdei A; Sándor N; Bajtay Z Immunol Lett; 2017 Sep; 189():64-72. PubMed ID: 28554712 [TBL] [Abstract][Full Text] [Related]
14. Potentiation of NK cytotoxicity by antibody-C3b/iC3b heteroconjugates. Yefenof E; Benizri R; Reiter Y; Klein E; Fishelson Z J Immunol; 1990 Feb; 144(4):1538-43. PubMed ID: 2303717 [TBL] [Abstract][Full Text] [Related]
16. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18). Vetvicka V; Thornton BP; Wieman TJ; Ross GD J Immunol; 1997 Jul; 159(2):599-605. PubMed ID: 9218574 [TBL] [Abstract][Full Text] [Related]
17. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan. Yan J; Vetvicka V; Xia Y; Hanikýrová M; Mayadas TN; Ross GD Immunopharmacology; 2000 Jan; 46(1):39-54. PubMed ID: 10665778 [TBL] [Abstract][Full Text] [Related]
18. Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18). Taniguchi-Sidle A; Isenman DE J Biol Chem; 1992 Jan; 267(1):635-43. PubMed ID: 1730624 [TBL] [Abstract][Full Text] [Related]
19. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. Ross GD; Cain JA; Lachmann PJ J Immunol; 1985 May; 134(5):3307-15. PubMed ID: 2984286 [TBL] [Abstract][Full Text] [Related]
20. A peptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11b/CD18 and CD11c/CD18. Li R; Xie J; Kantor C; Koistinen V; Altieri DC; Nortamo P; Gahmberg CG J Cell Biol; 1995 May; 129(4):1143-53. PubMed ID: 7744962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]